SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmacopeia, Inc. (ACCL) (Prev: PCOP)
ACCL 4.028+0.7%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Dwyer who wrote (14)7/24/1997 1:35:00 PM
From: kinkblot   of 179
 
John,

I checked out the Pharmacopeia website last night. In their description of the technology, they note that drug candidates synthesized by ECLiPS are typically 10 to 1000 times more potent than those developed by standard techniques, due to the smaller molecular size. They also generate more candidates by orders of magnitude, and can rapidly identify the structures of the active ones. What they've got is like a "sausage machine" for cranking out bioactive compounds.

The non-cash market value of the company is only around 100M. For that amount spent internally, a pharmaceutical company gets only a fraction of the capability they get by working with PCOP. So once the technique is validated by one of their partners with some clinical success, the value of the technology will be marked up quickly.

I've been following this stock casually since the IPO, although I've never owned it. The stock has followed a pattern typical for many IPOs, e.g. HGSI. Now it looks to me like the basing out period is completed. I made an initial purchase this morning at price 14 3/4, and will buy more if it moves up. My technical indicators tell me that the stock is under accumulation and should begin to move up soon.

Will
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News